Advertisement

Adrenocortical tumors

  • O. Peter Schumacher
Part of the Cancer Treatment and Research book series (CTAR, volume 20)

Abstract

Adrenocortical nodules more than a centimeter in diameter are found in approximately 1.5–8.7% of unselected postmortem examinations [1, 2] and are more frequent in older people and those with high blood pressure. Benign nonfunctional adrenocortical tumors [3] are only rarely diagnosed during life but may be diagnosed more with the increasing use of CT scans [4, 5], particularly sector CT scans and abdominal ultrasound studies. Malignant nonfunctional tumors are also very infrequent, comprising only about 0.2% of all reported carcinomas [6].

Keywords

Plasma Cortisol Primary Aldosteronism Urinary Free Cortisol Adrenocortical Carcinoma Adrenocortical Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Symington T: Functional Pathology of the Human Adrenal Gland. Baltimore: Williams & Wilkins, 1969, p 151.Google Scholar
  2. 2.
    Hedeland H, Ostberg G, Hokfelt B: On the prevalence of adrenocritical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184: 211, 1968.PubMedCrossRefGoogle Scholar
  3. 3.
    Shamma AH, Goddard JW, Sommers SC: A study of the adrenal status in hypertension. J Chronic Dis 8: 587, 1958.PubMedCrossRefGoogle Scholar
  4. 4.
    Prinz RA, Brooks MH, Churchill R, et al.: Incidental asymptomatic adrenal masses detected by computed tomographic scanning: Is operation required? JAMA 248: 701, 1982.PubMedCrossRefGoogle Scholar
  5. 5.
    Siekavizza JL, Bernardino ME, Sammaan NA; Suprarenal mass and its differential diagnosis. Urology 18: 625, 1981.PubMedCrossRefGoogle Scholar
  6. 6.
    Lipsett MB, Hertz R, Ross GT: Clinical and pathophysiologic aspects of adrenocortical carcinoma. Am J Med 35:374, 1963.PubMedCrossRefGoogle Scholar
  7. 7.
    Bertagna C, Orth DN: Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a singly medical center (1951 to 1978). Amer J Med 71: 855, 1981.PubMedCrossRefGoogle Scholar
  8. 8.
    Yalow RS, Glick SM, Roth J, Berson SA: Radioimmunoassay of plasma ACTH. J Clin Endo Metab 24: 1219, 1964.CrossRefGoogle Scholar
  9. 9.
    Liddle GW, Nicholson WE, et al.: Clinical and laboratory studies of ectopic humoral syndromes. Recent Progr Horm Res 25: 238, 1969.Google Scholar
  10. 10.
    Appleby JI, Gibson G, Norymberski JK, Stubbs RD: Indirect analysis of corticosteroids. Biochem J 60:453, 1955.PubMedGoogle Scholar
  11. 11.
    Porter CC, Silber RH: A quantitative color reaction for cortisone and related 17, 21 dihydroxy-20 ketosteroids. J Biol Chem 185: 201, 1950.PubMedGoogle Scholar
  12. 12.
    Mattingly D: A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Path 15: 374, 1962.PubMedCrossRefGoogle Scholar
  13. 13.
    Ruder HJ, Guy RL, Lipsett MB: A radioimmunoassay for Cortisol in plasma and urine. J Clin Endo Metab 35: 219, 1972.CrossRefGoogle Scholar
  14. 14.
    Bravo EL, Tarazi RC, Dustan HP, et al.: The changing clinical spectrum of primary aldosteronism. Amer J Med 74:641, 1983.PubMedCrossRefGoogle Scholar
  15. 15.
    Buster JE, Abraham CE: Radioimmunoassay of plasma dehydroepiandrosterone sulphate. Analytical letters 5: 543, 1972.Google Scholar
  16. 16.
    Youssefnejadian E, Florensa E, Collins WP, Sommerville IF: Radioimmunoassay of 17-hydroxyprogesterone. Steroids 20: 773, 1972.PubMedCrossRefGoogle Scholar
  17. 17.
    Rose LI, William GH, Jagger PI, Lauler DP: The 48-hour adrenocorticotropin infusion test for adrenocortical insufficiency. Ann Int Med 73: 49, 1970.PubMedGoogle Scholar
  18. 18.
    Sheeler LR, Schumacher OP: Letter to the Editor: Hyponatremia during ACTH infusions. Ann Int Med 90: 709, 1979.Google Scholar
  19. 19.
    Liddle GW, Estep HL, et al.: Clinical application of a new test of pituitary reserve. J Clin Endo 19: 875, 1969.CrossRefGoogle Scholar
  20. 20.
    Newsome HH, Clements AS, Borum EH: The simultaneous assay of Cortisol, corticosterone, 11-Deoxycortisol, and cortisone in human plasma. J Clin Endo Metab 34: 743, 1972.CrossRefGoogle Scholar
  21. 21.
    Liddle GW: Test of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome. J Clin Endo 20: 1539, 1960.CrossRefGoogle Scholar
  22. 22.
    Hayles AB, Hahn HB, Sprague RG, et al.: Hormone-secreting tumors of the adrenal cortex in children. Pediatrics 37: 19, 1966.PubMedGoogle Scholar
  23. 23.
    Nelson AA, Woodard G: Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2, 2-bis (parachlorophenyl 1–1, 1-dichloroethane (DDP or TDE). Arch Pathol 48: 387, 1949.Google Scholar
  24. 24.
    Chambers EF, Turski PA, LaMasters D, Newton TH: Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes. Radiology 144: 109, 1982.PubMedGoogle Scholar
  25. 25.
    Swartz JD, Russell KB, Basile BA, et al.: High resolution computed tomographic appearance of the intrasellar contents in women of childbearing age. Radiology 147: 115, 1983.PubMedGoogle Scholar
  26. 26.
    Beierwaltes WH, Lieberman LM, Ansari AN, Nishiyama H: Visualization of human adrenal glands in vivo by scintillation scanning. JAMA 216: 275, 1971.PubMedCrossRefGoogle Scholar
  27. 27.
    Lieberman LM, Beierwaltes WH, Conn JW, et al.: Diagnosis of adrenal disease by visualization of human adrenal glands with 131I-19 iodocholesterol. N Engl J Med 285, 1387, 1971.PubMedCrossRefGoogle Scholar
  28. 28.
    Morita R, Lieberman LM, Beierwaltes WH, et al.: Percent uptake of 131I-radioactivity in the adrenal from radioiodinated cholester. J Clin Endo Metab 37: 36, 1972.CrossRefGoogle Scholar
  29. 29.
    Sarkar SD, Beierwaltes WH, Ice RD, et al.: A new and superior adrenal scanning agent, NP-59. J Nuc Med 16: 1038, 1975.Google Scholar
  30. 30.
    Schteingart DE, Seabold JE, Gross MD, Swanson DP: Iodocholesterol adrenal tissue uptake and imaging in adrenal neoplasms. J Clin Endo Metab 52: 1156, 1981.CrossRefGoogle Scholar
  31. 31.
    Wieland DM, Brown LE, Tobes MX, et al.: Imaging the primate adrenal medullae with [123I] and [131I] meta-iodobenzylguanidine; concise communication. J Nuc Med 22: 358, 1981.Google Scholar
  32. 32.
    Wieland DM, Wu JI, Brown LE, et al.: Radiolabeled adrenergic neuronblocking agents; adrenomedullary imaging with [131I] iodobenzylguanidine. J Nuc Med 21: 349, 1980.Google Scholar
  33. 33.
    Liddle GW: The Adrenals. Textbook of Endocrinology, Sixth Edition, Robert H. Williams. Philadelphia: WB Saunders Co., pp 249–292.Google Scholar
  34. 34.
    Cueto C, Brown JHU: Biological studies of an adrenocorticolytic agent and the isolation of the active components. Arch Int Med 138: 301, 1978.CrossRefGoogle Scholar
  35. 35.
    Becker D, Schumacher OP: o,p’DDD therapy in invasive adrenocortical carcinoma. Ann Int Med 82: 677, 1975.PubMedGoogle Scholar
  36. 36.
    Bergenstal DM, Hertz R, Lipsett MS, Moy RH: Chemotherapy of adrenocortical cancer with o,p’DDD. Ann Int Med 53: 672, 1960.Google Scholar
  37. 37.
    Downing V, Eule J, Juseby RA: Regression of an adrenal cortical carcinoma and its neovascular bed following Mitotane therapy: A case report. Cancer: 34: 1882, 1974.PubMedCrossRefGoogle Scholar
  38. 38.
    Hoffman DL, Mattox VR: Treatment of adrenocortical carcinoma with o,p’DDD. Med Clin N A 56: 999, 1972.Google Scholar
  39. 39.
    Hutter AM, Kayhole DE: Adrenocortical carcinoma— results of treatment with o,p’DDD in 138 patients. Am J Med 41: 581, 1966.PubMedCrossRefGoogle Scholar
  40. 40.
    Newton MA, Laragh JH: Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects in essential hypertension and in primary aldosteronism. J Clin Endo 28: 1006, 1968.CrossRefGoogle Scholar
  41. 41.
    Halmi KA, Lascari AD: Conversion of virilization to feminization in a young girl with adrenal carcinoma. Cancer 27: 931, 1971.PubMedCrossRefGoogle Scholar
  42. 42.
    Ostruni JA, Roginsky MS: Metastatic adrenal carcinoma documented cure with combined chemotherapy. Arch Int Med 135: 1257, 1975.CrossRefGoogle Scholar
  43. 43.
    MacFarlane DA: Cancer of the adrenal cortex — the natural history, prognosis and treatment in a study of fifty-five cases. Ann Royal Coll of Surg of Engl 23: 155, 1958.Google Scholar
  44. 44.
    Lubitz JA, Freeman L, Okun R: Mitotane use in inoperable adrenal cortical carcinoma. JAMA 223: 1109, 1973.PubMedCrossRefGoogle Scholar
  45. 45.
    Bravo EL: The clinical values of plasma catecholamine measurement. Lab Mgmt, 1982.Google Scholar
  46. 46.
    Bravo EL: Pheochromocytoma: current concepts in diagnosis, localization, and management. Primary Care 10: 75, 1983.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1984

Authors and Affiliations

  • O. Peter Schumacher

There are no affiliations available

Personalised recommendations